Karolinska Institutet (KI) is one of the world’s leading medical universities. Its vision is to advance knowledge about life and strive towards better health for all. KI accounts for the single largest share of all academic medical research conducted in Sweden. KI furthermore offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at KI selects the Nobel laureates in Physiology or Medicine. Research at KI spans the entire medical field, from basic experimental research to patient-oriented and nursing research. KI has access to a large number of infrastructural solutions in areas such as imaging, biostatistics, biobanking, proteomics, and genomics. The establishment of Science for Life Laboratory (SciLifeLab) as a national infrastructure gives researchers from all over Sweden access to modern instruments for technically demanding, large-scale research projects. The Institute of Environmental Medicine (IMM) is a department at KI as well as a national institute devoted to provide authorities in Sweden and abroad with expertise, support and advice regarding environmental health risk assessments. IMM has about 350 employees and research topics are covered in the areas of epidemiology, toxicology, physiology, environmental medicine, and risk assessment.

The research performed at IMM (KI) includes areas of main relevance for the tasks in the proposal; toxicology, epidemiology, physiology, environmental medicine, and risk assessment. Furthermore, the field of nanotoxicology has been an important focus area at IMM for several years, and IMM is host of the National Nano Safety Platform, SweNanoSafe. The fact that particle toxicology and nanotoxicology have been important research areas at IMM has led to the development of competences of great importance for the tasks in the proposal. All equipment needed for performing cell culturing and toxicity testing is available at IMM.